Aya Mohamed, MSc, MD 🎗 (@dr_oncologista) 's Twitter Profile
Aya Mohamed, MSc, MD 🎗

@dr_oncologista

MSc | MD Oncolog🎗 #breastcancer & Researcher 🧬 |Certified by the American and European Boards. Associate lecturer of medical Oncologist•
Member @ASCO @MyESMO

ID: 1157309656123023361

calendar_today02-08-2019 15:18:18

674 Tweet

1,1K Followers

617 Following

Aya Mohamed, MSc, MD 🎗 (@dr_oncologista) 's Twitter Profile Photo

Evaluation of 3 studies from the West Germany Study group (WSG) showing that neoadjuvant regimens WITHOUT CT in HER2 positive patients had very good survival results and were comparable to regimens with CT! ◽Excellent discussion by Dr. Sara Hurvitz. ASCO OncoAlert #ASCO25

Evaluation of 3 studies from the West Germany Study group (WSG) showing that neoadjuvant regimens WITHOUT CT in HER2 positive patients had very good survival results and were comparable to regimens with CT!

◽Excellent discussion  by Dr. Sara Hurvitz. 

<a href="/ASCO/">ASCO</a> <a href="/OncoAlert/">OncoAlert</a> #ASCO25
Aya Mohamed, MSc, MD 🎗 (@dr_oncologista) 's Twitter Profile Photo

ELINZANETANT for vasomotor symptoms due to hormone therapy in localized #BreastCancer disease. ◽Rationale behind the drug's activity, an NK1 and NK3 receptor antagonist. ◽Significant reduction in the frequency and intensity of vasomotor symptoms. OncoAlert #ASCO25 #bcsm

ELINZANETANT for vasomotor symptoms due to hormone therapy in localized #BreastCancer disease.
 
◽Rationale behind the drug's activity, an NK1 and NK3 receptor antagonist. 

◽Significant reduction in the frequency and intensity of vasomotor symptoms. 

<a href="/OncoAlert/">OncoAlert</a> #ASCO25 #bcsm
ASCO (@asco) 's Twitter Profile Photo

We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗

LARVOL (@larvol) 's Twitter Profile Photo

Top #BreastCancer Oncologists from ASCO 2025. Follow us for more #ASCO25 updates: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | Paolo Tarantino | Yakup Ergün | Kazuki Nozawa, MD | Harold J. Burstein, MD, PhD, FASCO |

Top #BreastCancer Oncologists from <a href="/ASCO/">ASCO</a> 2025.

Follow us for more #ASCO25 updates: t.ly/7TCD6

#LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | <a href="/PTarantinoMD/">Paolo Tarantino</a> | <a href="/dr_yakupergun/">Yakup Ergün</a> | <a href="/kazuki_nozawa/">Kazuki Nozawa, MD</a> | <a href="/DrHBurstein/">Harold J. Burstein, MD, PhD, FASCO</a> |
LARVOL (@larvol) 's Twitter Profile Photo

Reactions on top trials during ASCO 2025 curated by LARVOL CLIN. Follow us for more #ASCO25 updates: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | Aakash Desai, MD, MPH, FASCO | Dr Amol Akhade | Aya Mohamed | MSc, MD 🎗 | Diego A. Díaz García |

Reactions on top trials during <a href="/ASCO/">ASCO</a> 2025 curated by <a href="/Larvol/">LARVOL</a> CLIN.

Follow us for more #ASCO25 updates: t.ly/7TCD6

#LARVOL #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | <a href="/ADesaiMD/">Aakash Desai, MD, MPH, FASCO</a> | <a href="/SuyogCancer/">Dr Amol Akhade</a> | <a href="/Dr_Oncologista/">Aya Mohamed | MSc, MD 🎗</a> | <a href="/diegoadiazg/">Diego A. Díaz García</a> |
LARVOL (@larvol) 's Twitter Profile Photo

Top 10 Trials in #BreastCancer for May 2025, curated by LARVOL CLIN based on the sentiments among top oncologists on X, are here! Discover more about oncology conferences, top trials, and reactions from the oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch

Top 10 Trials in #BreastCancer for May 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN based on the sentiments among top oncologists on X, are here!

Discover more about oncology conferences, top trials, and reactions from the oncologists: clin.larvol.com

#LARVOL #Oncology #CancerResearch
Aya Mohamed, MSc, MD 🎗 (@dr_oncologista) 's Twitter Profile Photo

HR+in metastatic #breastcancer We stay away from chemotherapy as much as possible. Cuz we have much more targeted, effective and tolerable treatment options! The next step is to perform a new biopsy and re-evaluate the genetic profile of the tumor with up-to-date molecular tests

HR+in metastatic #breastcancer
We stay away from chemotherapy as much as possible.
Cuz we have much more targeted, effective and  tolerable treatment options!
The next step is to perform a new biopsy and re-evaluate the genetic profile of the tumor with up-to-date molecular tests
LARVOL (@larvol) 's Twitter Profile Photo

Top 10 #BreastCancer Trials for June 2025, curated by LARVOL CLIN based on oncologist sentiment on X. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights |

Top 10 #BreastCancer Trials for June 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN based on oncologist sentiment on X.

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights |
LARVOL (@larvol) 's Twitter Profile Photo

Top 10 #BreastCancer Oncologists for June 2025, curated by LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | Paolo Tarantino | Bishal Gyawali, MD, PhD, FASCO

Top 10 #BreastCancer Oncologists for June 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN.

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com 

#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | <a href="/PTarantinoMD/">Paolo Tarantino</a> | <a href="/oncology_bg/">Bishal Gyawali, MD, PhD, FASCO</a>
LARVOL (@larvol) 's Twitter Profile Photo

Top #BreastCancer Trials for Q2 2025, curated by LARVOL CLIN based on oncologist sentiment on X. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights |

Top #BreastCancer Trials for Q2 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN based on oncologist sentiment on X.

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights |
LARVOL (@larvol) 's Twitter Profile Photo

Top #BreastCancer Oncologists for Q2 2025, curated by LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | Paolo Tarantino | Yakup Ergün |

Top #BreastCancer Oncologists for Q2 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN.

Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com 

#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | <a href="/PTarantinoMD/">Paolo Tarantino</a> | <a href="/dr_yakupergun/">Yakup Ergün</a> |
LARVOL (@larvol) 's Twitter Profile Photo

Top Women Oncologists for Q2 2025, curated by LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | Sharlene Gill, MD, MPH, MBA, FASCO | Aya Mohamed | MSc, MD 🎗 |

Top Women Oncologists for Q2 2025, curated by <a href="/Larvol/">LARVOL</a> CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com

#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights | <a href="/GillSharlene/">Sharlene Gill, MD, MPH, MBA, FASCO</a> | <a href="/Dr_Oncologista/">Aya Mohamed | MSc, MD 🎗</a> |